Elizabeth Wurtzel Helped Clear the Air on Stigma Elizabeth Wurtzel Helped Clear the Air on Stigma
"Prozac Nation" author's honesty was good for psychiatry, Dr Robert T. London writes.Medscape Psychiatry (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 14, 2020 Category: Consumer Health News Tags: Psychiatry Commentary Source Type: news

DR MICHAEL MOSLEY: Could magic mushrooms be the new Prozac?
A chemical called psilocybin, originally found in magic mushrooms, is being hailed as a potential lifesaver for people with depression. So is the hype justified, asks DR MICHAEL MOSLEY. (Source: the Mail online | Health)
Source: the Mail online | Health - February 8, 2020 Category: Consumer Health News Source Type: news

Increased circulatory IL-6 during 8-week fluoxetine treatment is a risk factor for suicidal behaviors in youth - Amitai M, Taler M, Ben-Baruch R, Lebow M, Rotkopf R, Apter A, Fennig S, Weizman A, Chen A.
OBJECTIVE: Selective serotonin reuptake inhibitors (SSRIs) are commonly used to treat anxiety and/or depression in pediatric populations. However, the response rates are low (approximately 50%). Moreover, SSRI use is frequently associated with adverse even... (Source: SafetyLit)
Source: SafetyLit - January 1, 2020 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Using antidepressants while pregnant can increase the risk of autism in newborns – study
(Natural News) Pregnant women can add antidepressants to their laundry list of things to avoid during pregnancy. The results of a recent study revealed that babies exposed to the pharmaceutical drug fluoxetine in the womb could develop autistic-like behavior later on. The study, published in the journal Molecular Brain, also identified a potential therapy for the problem,... (Source: NaturalNews.com)
Source: NaturalNews.com - December 3, 2019 Category: Consumer Health News Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 30mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules has been varied... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 20, 2019 Category: Drugs & Pharmacology Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 40mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 40mg capsules ... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - November 8, 2019 Category: Drugs & Pharmacology Source Type: news

Amendments to Serious Shortage Protocols for fluoxetine 30mg and 40mg capsules (England)
The Serious Shortage Protocols (SSP) for fluoxetine 30mg capsules and fluoxetine 40mg capsules are being varied to extend the end date, which was previously 31 October 2019. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 30, 2019 Category: Drugs & Pharmacology Source Type: news

Withdrawal of Serious Shortage Protocol for fluoxetine 10mg capsule (England)
The Department of Health and Social Care (DHSC) has issued information about the withdrawal of Serious Shortage Protocol (SSP) for fluoxetine 10mg. (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 25, 2019 Category: Drugs & Pharmacology Source Type: news

Effect of Fluoxetine on Repetitive Behaviors in ASD Youth Unclear
WEDNESDAY, Oct. 23, 2019 -- Treatment with fluoxetine results in significantly lower scores for obsessive compulsive behaviors at 16 weeks among children and adolescents with autism spectrum disorder (ASD), according to a study published in the Oct.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - October 23, 2019 Category: Pharmaceuticals Source Type: news

Antidepressant Prozac Doesn't Ease Obsessive Behaviors of Autism
TUESDAY, Oct. 22, 2019 -- The commonly used antidepressant Prozac doesn't appear to help reduce obsessive-compulsive behavior in children and teens with autism, new research suggests. The study randomly compared use of the drug to a placebo over 16... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 22, 2019 Category: General Medicine Source Type: news

Lexapro vs. Prozac
Title: Lexapro vs. ProzacCategory: MedicationsCreated: 10/21/2019 12:00:00 AMLast Editorial Review: 10/21/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - October 21, 2019 Category: Psychiatry Source Type: news

What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

Featured review: What are the effects of fluoxetine treatment in overweight or obese adults?
Fluoxetine is a medicine used for the treatment of depression, which reduces appetite as a side effect. Therefore, it is suspected that fluoxetine could be used as a treatment for overweight or obese people. In this group of people administration of fluoxetine means an off-label treatment which means it is not licensed for treating obesity.The authors identified 19 randomised controlled trials (clinical studies where people are randomly put into one of two or more treatment groups) evaluating mainly women receiving different doses of fluoxetine. A total of 1280 overweight or obese participants received fluoxetine and 936 p...
Source: Cochrane News and Events - October 17, 2019 Category: Information Technology Authors: Katie Abbotts Source Type: news

Serious shortage protocols (SSPs) for Fluoxetine (England)
The Department of Health and Social Care has agreed the October serious shortage protocols for the following items... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2019 Category: Drugs & Pharmacology Source Type: news

First Serious Shortage Protocols issued
The Government has authorised the first Serious Shortage Protocols (SSP), for the antidepressant fluoxetine, enabling pharmacists in England to supply an alternative strength or pharmaceutical form of (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - October 3, 2019 Category: Drugs & Pharmacology Source Type: news

NHS doctors warned to limit prescriptions of Prozac because of stock shortages
Doctors in England have been warned not to give patients repeat prescriptions if they have enough of the drug to last until November because the pills are in short supply. (Source: the Mail online | Health)
Source: the Mail online | Health - September 26, 2019 Category: Consumer Health News Source Type: news

Drug Supply issues: Provera100mg tablets and fluoxetine capsules
Information from the Department of Health and Social Care (DHSC) regarding the following supply issues... (Source: Royal Pharmaceutical Society News)
Source: Royal Pharmaceutical Society News - September 20, 2019 Category: Drugs & Pharmacology Source Type: news

Study shows how serotonin and a popular anti-depressant affect the gut ’s microbiota
In this study, we were interested in finding out why they might do so,” said Hsiao, UCLA assistant professor of integrative biology and physiology, and of microbiology, immunology and molecular genetics in the  UCLA College; and of digestive diseases in the David Geffen School of Medicine at UCLA.Hsiao and her research group reported in the journal Cell in 2015 that in mice, a specific mixture of bacteria, consisting mainly of  Turicibacter sanguinis and Clostridia, produces molecules that signal to gut cells to increase production of serotonin. When Hsiao’s team raised mice without the bact...
Source: UCLA Newsroom: Health Sciences - September 6, 2019 Category: Universities & Medical Training Source Type: news

Psychotherapy Alone First Line of Treatment for Depressed Youth
Adding fluoxetine to cognitive behavioral therapy did not further reduce depressive symptoms (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - August 12, 2019 Category: Psychiatry Tags: Family Medicine, Pediatrics, Pharmacy, Psychiatry, Journal, Source Type: news

The addition of fluoxetine to cognitive behavioural therapy for youth depression (YoDA-C): a randomised, double-blind, placebo-controlled, multicentre clinical trial - Davey CG, Chanen AM, Hetrick SE, Cotton SM, Ratheesh A, Amminger GP, Koutsogiannis J, Phelan M, Mullen E, Harrison BJ, Rice S, Parker AG, Dean OM, Weller A, Kerr M, Quinn AL, Catania L, Kazantzis N, McGorry PD, Berk M.
BACKGROUND: Medication is commonly used to treat youth depression, but whether medication should be added to cognitive behavioural therapy (CBT) as first-line treatment is unclear. We aimed to examine whether combined treatment with CBT and fluoxetine was ... (Source: SafetyLit)
Source: SafetyLit - August 4, 2019 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

How a popular antidepressant drug could rewire the brain
(American Chemical Society) Prozac ® , the trade name for the drug fluoxetine, was introduced to the US market for the treatment of depression in 1988. Thirty years later, scientists still don't know exactly how the medication exerts its mood-lifting effects. Now, researchers report that, in addition to the drug's known action on serotonin receptors, fluoxetine could rearrange nerve fibers in the hippocampus of mouse brains. They report their results in ACS Chemical Neuroscience. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 10, 2019 Category: International Medicine & Public Health Source Type: news

Medical News Today: What are the differences between Prozac and Zoloft?
Prozac and Zoloft are two types of antidepressant. In this article, we compare the uses, dosages, and side effects of the two drugs. We also look at their interactions with other medicines and discuss whether people can take Prozac and Zoloft together. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - July 8, 2019 Category: Consumer Health News Tags: Depression Source Type: news

fluoxetine (Prozac, Sarafem, Prozac Weekly)
Title: fluoxetine (Prozac, Sarafem, Prozac Weekly)Category: MedicationsCreated: 12/31/1997 12:00:00 AMLast Editorial Review: 7/3/2019 12:00:00 AM (Source: MedicineNet Depression General)
Source: MedicineNet Depression General - July 3, 2019 Category: Psychiatry Source Type: news

Zoloft (sertraline) vs. Prozac (fluoxetine)
Title: Zoloft (sertraline) vs. Prozac (fluoxetine)Category: MedicationsCreated: 6/26/2019 12:00:00 AMLast Editorial Review: 6/26/2019 12:00:00 AM (Source: MedicineNet Medications General)
Source: MedicineNet Medications General - June 26, 2019 Category: Drugs & Pharmacology Source Type: news

New Research Is Focusing on Treating Teens ’ Suicidal Thoughts With Support of Friends, Family
This article was originally published on Undark. Read the original article. (Source: TIME: Health)
Source: TIME: Health - June 24, 2019 Category: Consumer Health News Authors: Jill U. Adams / Undark Tags: Uncategorized mental health onetime syndication Source Type: news

AMP-Activated Protein Kinase: Potential Target for TNBC AMP-Activated Protein Kinase: Potential Target for TNBC
Metformin, fluoxetine, and other AMPK agonists significantly inhibit TNBC. Will targeted therapy finally become an option for this aggressive disease?Breast Cancer Research (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - April 26, 2019 Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news

Dorothy Rowe obituary
Psychologist who believed in listening to patients, and could express complex ideas with brilliant simplicityDorothy Rowe, who has died aged 88, was one of the earliest figures in psychology to build a bridge between the sometimes arcane world of clinical practice and the general public. Coming to prominence in the 1980s, particularly with her book Depression: The Way Out of Your Prison, she made a career around the principle of listening to the patient in matters of mental illness rather than simply seeing them as problems to be solved – often by drugs or ECT, what Dorothy called “the equivalent of blood-letti...
Source: Guardian Unlimited Science - April 11, 2019 Category: Science Authors: Tim Lott Tags: Psychology Education Science Higher education UK news Australia news World news Source Type: news

Lupin launches generic antidepressant tablets in US
The company has launched its Fluoxetine tablets USP in the strength of 60mg after having received an approval from the United States Food and Drug Administration. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 10, 2019 Category: Pharmaceuticals Source Type: news

Depression drugs: battling blues
The first new anti-depressant since Prozac provides hope amid the gloom (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - March 18, 2019 Category: Pharmaceuticals Source Type: news

This Ketamine-Like Drug Has Been Approved to Treat Depression
(WASHINGTON) — A mind-altering medication related to the club drug Special K won U.S. approval Tuesday for patients with hard-to-treat depression, the first in a series of long-overlooked substances being reconsidered for severe forms of mental illness. The nasal spray from Johnson & Johnson is a chemical cousin of ketamine, which has been used for decades as a powerful anesthetic to prepare patients for surgery. In the 1990s, the medication was adopted as a party drug by the underground rave culture due to its ability to produce psychedelic, out-of-body experiences. More recently, some doctors have given ketamin...
Source: TIME: Health - March 6, 2019 Category: Consumer Health News Authors: MATTHEW PERRONE / AP Tags: Uncategorized Drugs onetime overnight Source Type: news

Fast-Acting Depression Drug, Newly Approved, Could Help Millions
A nasal spray version of the drug ketamine has shown promise as an antidepressant, even if its properties still aren ’ t well understood. (Source: NYT Health)
Source: NYT Health - March 6, 2019 Category: Consumer Health News Authors: BENEDICT CAREY Tags: your-feed-science Depression (Mental) Mental Health and Disorders Antidepressants Drugs (Pharmaceuticals) Anxiety and Stress Prozac (Drug) Suicides and Suicide Attempts Food and Drug Administration Source Type: news

A commonly-used antidepressant doesn't improve recovery after stroke
The antidepressant fluoxetine works no better than placebo to reduce disability after a stroke, lowering hopes that had been raised by other smaller studies. After a six month trial including more than 3,000 adult stroke patients recruited at 103 UK hospitals, researchers concluded that fluoxetine should not be used to promote recovery from stroke-related disability, or routinely prescribed to prevent depression after stroke. Several smaller studies and animal trials had found promising results from the use of fluoxetine after stroke. However, this trial of fluoxetine 20mg daily for six months found no improvement in funct...
Source: Current Awareness Service for Health (CASH) - February 18, 2019 Category: Consumer Health News Source Type: news

Happy news: Curcumin outperforms prozac for reducing symptoms of depression
(Natural News) Depression has become an all too common condition in recent times. Despite its prevalence, however, pharmaceutical companies have failed to come up with a safe and effective way to address it. Lots of people think they either have to live with their negative feelings or accept the possibly deadly side effects that come... (Source: NaturalNews.com)
Source: NaturalNews.com - January 22, 2019 Category: Consumer Health News Source Type: news

Shocking research: Prozac could be driving the antibiotic resistance crisis
(Natural News) The Centers for Disease Control and Prevention (CDC) calls antibiotic resistance “a global threat” and “one of the biggest public health challenges of our time.” Antibiotic resistance occurs when bacteria and other germs develop the ability to beat the antibiotic drugs designed to kill them. Infections caused by these pathogens can be difficult... (Source: NaturalNews.com)
Source: NaturalNews.com - December 26, 2018 Category: Consumer Health News Source Type: news

Effects of Antidepressants Span Three Generations in Fish
Fluoxetine dampened stress responses in zebrafish embryos exposed to the drug--and their descendants. (Source: The Scientist)
Source: The Scientist - December 10, 2018 Category: Science Tags: News & Opinion Source Type: news

New "antidepressant food score" rates foods based on their ability to treat symptoms of depression
(Natural News) When the selective serotonin reuptake inhibitor (SSRI) Prozac first hit the market in 1988, around 2.5 million people were prescribed the drug. By 2002, that number had increased to 33 million. In the subsequent years, many other SSRIs have been produced and prescribed prolifically, with doctors handing them out like candy to anyone... (Source: NaturalNews.com)
Source: NaturalNews.com - December 2, 2018 Category: Consumer Health News Source Type: news

New Drug Option Fails for Rare Polio-Like Virus in Kids New Drug Option Fails for Rare Polio-Like Virus in Kids
Despite initial hope, fluoxetine failed to improve outcomes in children with acute flaccid myelitis and in some cases was linked to a worsening of the disorder, which can cause permanent paralysis in children.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 14, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

No Efficacy Signal for Fluoxetine in EV-D68 Acute Flaccid Myelitis
TUESDAY, Nov. 13, 2018 -- The antiviral agent fluoxetine is well tolerated but is not effective for patients with proven or presumptive enterovirus D68-associated acute flaccid myelitis (AFM), according to a study published online Nov. 9 in... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 13, 2018 Category: Pharmaceuticals Source Type: news

Prozac No Help In Polio-Like Illness
Researchers have been searching for possible treatments for acute flaccid myelitis, or AFM. Lab tests showed that fluoxetine had antiviral effects against a virus associated with the disorder, so some experts had suggested that the antidepressant might be a possible treatment for the disorder. (Source: WebMD Health)
Source: WebMD Health - November 9, 2018 Category: Consumer Health News Source Type: news

Some Researchers Thought This Drug Could Treat the Polio-Like Illness Sickening Children. A New Study Says It Probably Doesn ’t
Health officials are scrambling for answers — and cures — as a rare, polio-like illness called acute flaccid myelitis (AFM) spreads across the country. Some researchers thought the antidepressant fluoxetine, which is often sold under the brand name Prozac and has some antiviral properties, could work against AFM, a mysterious illness that strikes some children and can cause muscle weakness, breathing issues, paralysis and even death. A new study published Friday in Neurology, however, provides disappointing results: In a small, non-randomized retrospective study, fluoxetine did not seem to restore patients&rsqu...
Source: TIME: Health - November 9, 2018 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized Drugs healthytime onetime Source Type: news

Fluoxetine for Acute Flaccid Myelitis? (CME/CE)
(MedPage Today) -- Anti-enteroviral activity in vitro, but did not improve neurological outcomes in children (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - November 9, 2018 Category: American Health Source Type: news

Dead End for Treatment of Polio-Like Disorder Striking Kids
FRIDAY, Nov. 9, 2018 -- The antidepressant fluoxetine (Prozac) is ineffective in treating a rare, polio-like disorder that can cause muscle weakness and paralysis in children, researchers are reporting. In the United States, there have been 219... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - November 9, 2018 Category: General Medicine Source Type: news

How my £10,000 therapy inspired a new TV comedy
An ex-Observer journalist on her battle with depression, and the creation of a celebration of women with complicated livesNot long after my 30th birthday – which I spent cry-dancing in a random club with baffled strangers – I went to my GP and was diagnosed with depression. In some ways it was a relief. The feelings of hopelessness, inadequacy, unworthiness and loneliness with which I’d struggled since my teenage years finally had an explanatio n. It was caused by dodgy brain chemistry, serotonin deficiencies. Even better, there was a treatment and it was simple and easy to swallow.For the next five years...
Source: Guardian Unlimited Science - November 3, 2018 Category: Science Authors: Lorna Martin Tags: Mental health Psychology Psychiatry Depression Television Sharon Horgan Source Type: news

Strep Throat Could Trigger Debilitating Mental Illness In Kids
HOLLISTON (CBS) – Just about every kid comes down with strep throat at one time or another, but what many parents don’t realize is that common ailment could trigger a debilitating mental illness. That’s what happened to 18-year-old Patrick Dillon of Holliston. When he was in elementary school he suddenly developed severe obsessive-compulsive disorder and became paranoid. Patrick Dillon. (WBZ-TV) “He couldn’t be in the same room with his sisters,” his mother, Heather recalled. “My sister Susie especially. I wouldn’t go near her. I thought she was like, toxic,” Patrick to...
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 3, 2018 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall IVIG OCD PANDAS Source Type: news

Fluoxetine, Riluzole or Amiloride No Benefit in Progressive MS Fluoxetine, Riluzole or Amiloride No Benefit in Progressive MS
A new trial with an innovative multiarm design testing three drugs at the same time has shown no therapeutic benefit for any of them in secondary progressive MS.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 23, 2018 Category: Consumer Health News Tags: Neurology & Neurosurgery News Source Type: news

Why depression pills could be fuelling the rise of superbugs  
Research suggests that an ingredient in the commonly prescribed antidepressant fluoxetine — or Prozac — causes a mutation in some bacteria, making them resistant to antibiotics. (Source: the Mail online | Health)
Source: the Mail online | Health - September 25, 2018 Category: Consumer Health News Source Type: news

Book Review: Understanding Antidepressants
One in five Americans will have a major depressive episode in their lives and many will seek help from a mental health provider, which may include treatment with medication. As with all medication, there is no one-size-fits-all treatment plan when it comes to antidepressants. The terminology alone is confusing. There are SSRIs, tricyclics, and other drugs that have off-label uses. For those who take antidepressants, it is a challenge to find the right one. Some work better than others for individuals, and family members may not understand why it is difficult to find something that “works.” In Understanding Anti...
Source: Psych Central - September 23, 2018 Category: Psychiatry Authors: Tina Arnoldi Tags: Antidepressants Book Reviews Depression Disorders General Medications Psychology Treatment book on antidepressants understanding antidepressants Source Type: news